Jobaaj Stories
Founded in 1968, Blue Jet Healthcare is a company operating in the pharmaceutical and healthcare ingredient sector. Blue Jet Healthcare holds the distinction of being the pioneer manufacturer of saccharin and its derivatives, which are artificial sweeteners, within the Indian market.
Check this - Management Consulting Case Study-Reviving a Declining Fertilizer Manufacturer
Subsequently, they diversified their product range to include contrast media intermediates, vital components utilized in the field of CT scans and MRIs. The company primarily focuses on three key product categories:
- Contrast media intermediates
- High-intensity sweeteners
- Pharma intermediates and active pharmaceutical ingredients
On the 25th of October 2023, Blue Jet Healthcare Limited will be entering the capital market with an IPO of 24,285,160 Equity Shares of Rs 2 aggregating up to Rs 840.27 Crore. The price for the issue has been set at Rs 329 - Rs 346 Per Equity Share.
Blue Jet Healthcare Ltd's IPO consists solely of an Offer for Sale (OFS) and does not include any fresh issue component. The OFS portion of the IPO involves the sale of approximately 2,42,85,160 shares (around 242.85 lakh shares). At the upper price band of â‚ą346 per share, this translates to a total OFS size of â‚ą840.27 crore.
Read this - The Inspirational Journey of Radha Vembu: A Self-Made Billionaire
The entire OFS is being carried out by the promoters, with Akshay Bansarilal Arora offering 183.66 lakh shares and Shiven Akshay Arora offering 59.19 lakh shares in the OFS.
The issue of Blue Jet Healthcare Limited will be closed on the 27th of October 2023.
Will you be subscribing to this IPO?
Also, check- Successful Gaganyaan Test Despite Minor 'Anomaly' - Crew Escape Module Lands Safely
